These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2065276)

  • 41. Mesothelioma clinical presentation.
    Bueno R
    Chest; 1999 Dec; 116(6 Suppl):444S-445S. PubMed ID: 10619504
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intraoperative photodynamic therapy after pleuropneumonectomy in patients with malignant pleural mesothelioma: dose finding and toxicity results.
    Schouwink H; Rutgers ET; van der Sijp J; Oppelaar H; van Zandwijk N; van Veen R; Burgers S; Stewart FA; Zoetmulder F; Baas P
    Chest; 2001 Oct; 120(4):1167-74. PubMed ID: 11591556
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of first- or second-line irinotecan, cisplatin, and mitomycin in mesothelioma.
    Fennell DA; Steele JP; Shamash J; Evans MT; Wells P; Sheaff MT; Rudd RM; Stebbing J
    Cancer; 2007 Jan; 109(1):93-9. PubMed ID: 17146783
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Single-arm, open label study of pemetrexed plus cisplatin in chemotherapy naïve patients with malignant pleural mesothelioma: outcomes of an expanded access program.
    Obasaju CK; Ye Z; Wozniak AJ; Belani CP; Keohan ML; Ross HJ; Polikoff JA; Mintzer DM; Monberg MJ; Jänne PA;
    Lung Cancer; 2007 Feb; 55(2):187-94. PubMed ID: 17092602
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Extrapleural pneumonectomy in the setting of a multimodality approach to malignant mesothelioma.
    Sugarbaker DJ; Mentzer SJ; DeCamp M; Lynch TJ; Strauss GM
    Chest; 1993 Apr; 103(4 Suppl):377S-381S. PubMed ID: 8462329
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pleuropneumonectomy in the treatment of malignant pleural mesothelioma.
    Grondin SC; Sugarbaker DJ
    Chest; 1999 Dec; 116(6 Suppl):450S-454S. PubMed ID: 10619506
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An orthotopic implantation mouse model of human malignant pleural mesothelioma for in vivo photon counting analysis and evaluation of the effect of S-1 therapy.
    Yanagihara K; Tsumuraya M; Takigahira M; Mihara K; Kubo T; Ohuchi K; Seyama T
    Int J Cancer; 2010 Jun; 126(12):2835-46. PubMed ID: 19876922
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Malignant pleural mesothelioma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    ; Manegold C
    Ann Oncol; 2007 Apr; 18 Suppl 2():ii34-5. PubMed ID: 17491037
    [No Abstract]   [Full Text] [Related]  

  • 49. Orthotopic implantation of mesothelioma in the pneumonectomized immune-deficient rat: a model for innovative therapies.
    Prewitt TW; Lubensky IA; Pogrebniak HW; Pass HI
    Int J Cancer; 1993 Nov; 55(5):877-80. PubMed ID: 8244586
    [No Abstract]   [Full Text] [Related]  

  • 50. Chemotherapy in malignant mesothelioma: a review.
    Krarup-Hansen A; Hansen HH
    Cancer Chemother Pharmacol; 1991; 28(5):319-30. PubMed ID: 1914074
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro and in vivo studies of mesothelioma.
    Pass HI; Mew DJ
    J Cell Biochem Suppl; 1996; 24():142-51. PubMed ID: 8806096
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of natural interferon alpha, natural tumor necrosis factor alpha and their combination on human mesothelioma xenografts in nude mice.
    Ohnuma T; Szrajer L; Holland JF; Kurimoto M; Minowada J
    Cancer Immunol Immunother; 1993; 36(1):31-6. PubMed ID: 8422665
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Electroporation as a strategy to promote HtrA1 gene uptake and chemotherapy efficacy in a mouse model of mesothelioma.
    Spugnini EP; Cardillo I; Fanciulli M; Crispi S; Vincenzi B; Boccellino M; Quagliuolo L; Baldi A
    Front Biosci (Elite Ed); 2013 Jun; 5(3):974-81. PubMed ID: 23747913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies of a human mesothelioma.
    Behbehani AM; Hunter WJ; Chapman AL; Lin F
    Hum Pathol; 1982 Sep; 13(9):862-6. PubMed ID: 7106748
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of clinically relevant human-scid-mouse models in metastasis research.
    Schumacher U; Mitchell BS
    Trends Biotechnol; 1997 Jul; 15(7):239-41. PubMed ID: 9237403
    [No Abstract]   [Full Text] [Related]  

  • 56. Malignant mesothelioma and central nervous system metastases. Report of two cases, pooled analysis, and systematic review.
    Miller AC; Miettinen M; Schrump DS; Hassan R
    Ann Am Thorac Soc; 2014 Sep; 11(7):1075-81. PubMed ID: 25079105
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pleuro-pulmonary tumours detected by clinical and chest X-ray analyses in rats transplanted with mesothelioma cells.
    Le Pimpec-Barthes F; Bernard I; Abd Alsamad I; Renier A; Kheuang L; Fleury-Feith J; Devauchelle P; Quintin Colonna F; Riquet M; Jaurand MC
    Br J Cancer; 1999 Dec; 81(8):1344-50. PubMed ID: 10604731
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cerebral metastases in pleural mesothelioma: case report and review of the literature.
    Wroński M; Burt M
    J Neurooncol; 1993 Jul; 17(1):21-6. PubMed ID: 8120568
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Usefulness of the nude mouse model in mesothelioma based on a direct patient-xenograft comparison.
    Chahinian AP; Kirschner PA; Gordon RE; Szrajer L; Holland JF
    Cancer; 1991 Aug; 68(3):558-60. PubMed ID: 2065276
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Experimental and clinical activity of mitomycin C and cis-diamminedichloroplatinum in malignant mesothelioma.
    Chahinian AP; Norton L; Holland JF; Szrajer L; Hart RD
    Cancer Res; 1984 Apr; 44(4):1688-92. PubMed ID: 6423278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.